Critical developments in cancer immunotherapy:
Cancer still poses a significant challenge in healthcare since traditional treatments often fail to produce desired results and patient outcomes. Conventional therapies, like chemotherapy and radiation, can have substantial side effects and may not always be able to eliminate cancer cells. Moreover,...
Gespeichert in:
| Weitere Verfasser: | , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Hershey, Pennsylvania
IGI Global
2024
|
| Schriftenreihe: | Advances in medical diagnosis, treatment, and care (AMDTC) book series
|
| Schlagworte: | |
| Online-Zugang: | DE-91 Volltext |
| Zusammenfassung: | Cancer still poses a significant challenge in healthcare since traditional treatments often fail to produce desired results and patient outcomes. Conventional therapies, like chemotherapy and radiation, can have substantial side effects and may not always be able to eliminate cancer cells. Moreover, the heterogeneity of tumors and individual responses to treatment create barriers to achieving consistent and long-lasting outcomes. Critical Developments in Cancer Immunotherapy offers a compelling solution to these challenges by delving into the cutting-edge field of cancer immunotherapy. This book provides a comprehensive guide to the latest advancements in harnessing the body's immune system to fight cancer. Focusing on critical strategies like checkpoint inhibitors and CAR T-cell therapy, the book provides insights into novel approaches that offer greater precision and effectiveness in cancer treatment. |
| Beschreibung: | 1 Online-Ressource (xxi, 626 Seiten) |
| DOI: | 10.4018/979-8-3693-3976-3 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV049869565 | ||
| 003 | DE-604 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 240917s2024 |||| o||u| ||||||eng d | ||
| 020 | |z 9798369339770 |9 9798369339770 | ||
| 024 | 7 | |a 10.4018/979-8-3693-3976-3 |2 doi | |
| 035 | |a (ZDB-98-IGB)00337789 | ||
| 035 | |a (DE-599)BVBBV049869565 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-91 | ||
| 082 | 0 | |a 616.994061 | |
| 084 | |a WIR 523 |2 stub | ||
| 084 | |a DAT 000 |2 stub | ||
| 245 | 1 | 0 | |a Critical developments in cancer immunotherapy |c Mohsen Sheykhhasan, Piao Yang, Naresh Poondla, editors |
| 264 | 1 | |a Hershey, Pennsylvania |b IGI Global |c 2024 | |
| 300 | |a 1 Online-Ressource (xxi, 626 Seiten) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Advances in medical diagnosis, treatment, and care (AMDTC) book series | |
| 520 | |a Cancer still poses a significant challenge in healthcare since traditional treatments often fail to produce desired results and patient outcomes. Conventional therapies, like chemotherapy and radiation, can have substantial side effects and may not always be able to eliminate cancer cells. Moreover, the heterogeneity of tumors and individual responses to treatment create barriers to achieving consistent and long-lasting outcomes. Critical Developments in Cancer Immunotherapy offers a compelling solution to these challenges by delving into the cutting-edge field of cancer immunotherapy. This book provides a comprehensive guide to the latest advancements in harnessing the body's immune system to fight cancer. Focusing on critical strategies like checkpoint inhibitors and CAR T-cell therapy, the book provides insights into novel approaches that offer greater precision and effectiveness in cancer treatment. | ||
| 650 | 4 | |a Cancer |x Immunotherapy | |
| 650 | 4 | |a Immunotherapy | |
| 700 | 1 | |a Poondla, Naresh |4 edt | |
| 700 | 1 | |a Sheykhhasan, Mohsen |4 edt | |
| 700 | 1 | |a Yang, Piao |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9798369339763 |
| 856 | 4 | 0 | |u https://doi.org/10.4018/979-8-3693-3976-3 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-98-IGB | ||
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-035209066 | |
| 966 | e | |u https://doi.org/10.4018/979-8-3693-3976-3 |l DE-91 |p ZDB-98-IGB |q TUM_Paketkauf_2024 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1810452464957128704 |
|---|---|
| adam_text | |
| any_adam_object | |
| author2 | Poondla, Naresh Sheykhhasan, Mohsen Yang, Piao |
| author2_role | edt edt edt |
| author2_variant | n p np m s ms p y py |
| author_facet | Poondla, Naresh Sheykhhasan, Mohsen Yang, Piao |
| building | Verbundindex |
| bvnumber | BV049869565 |
| classification_tum | WIR 523 DAT 000 |
| collection | ZDB-98-IGB |
| ctrlnum | (ZDB-98-IGB)00337789 (DE-599)BVBBV049869565 |
| dewey-full | 616.994061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.994061 |
| dewey-search | 616.994061 |
| dewey-sort | 3616.994061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Informatik Wirtschaftswissenschaften Medizin |
| doi_str_mv | 10.4018/979-8-3693-3976-3 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nmm a2200000zc 4500</leader><controlfield tag="001">BV049869565</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">240917s2024 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9798369339770</subfield><subfield code="9">9798369339770</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.4018/979-8-3693-3976-3</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-98-IGB)00337789</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV049869565</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-91</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.994061</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WIR 523</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">DAT 000</subfield><subfield code="2">stub</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Critical developments in cancer immunotherapy</subfield><subfield code="c">Mohsen Sheykhhasan, Piao Yang, Naresh Poondla, editors</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hershey, Pennsylvania</subfield><subfield code="b">IGI Global</subfield><subfield code="c">2024</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xxi, 626 Seiten)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Advances in medical diagnosis, treatment, and care (AMDTC) book series</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Cancer still poses a significant challenge in healthcare since traditional treatments often fail to produce desired results and patient outcomes. Conventional therapies, like chemotherapy and radiation, can have substantial side effects and may not always be able to eliminate cancer cells. Moreover, the heterogeneity of tumors and individual responses to treatment create barriers to achieving consistent and long-lasting outcomes. Critical Developments in Cancer Immunotherapy offers a compelling solution to these challenges by delving into the cutting-edge field of cancer immunotherapy. This book provides a comprehensive guide to the latest advancements in harnessing the body's immune system to fight cancer. Focusing on critical strategies like checkpoint inhibitors and CAR T-cell therapy, the book provides insights into novel approaches that offer greater precision and effectiveness in cancer treatment.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Immunotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunotherapy</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Poondla, Naresh</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sheykhhasan, Mohsen</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yang, Piao</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9798369339763</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.4018/979-8-3693-3976-3</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-98-IGB</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-035209066</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.4018/979-8-3693-3976-3</subfield><subfield code="l">DE-91</subfield><subfield code="p">ZDB-98-IGB</subfield><subfield code="q">TUM_Paketkauf_2024</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV049869565 |
| illustrated | Not Illustrated |
| indexdate | 2024-09-17T14:06:56Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-035209066 |
| open_access_boolean | |
| owner | DE-91 DE-BY-TUM |
| owner_facet | DE-91 DE-BY-TUM |
| physical | 1 Online-Ressource (xxi, 626 Seiten) |
| psigel | ZDB-98-IGB ZDB-98-IGB TUM_Paketkauf_2024 |
| publishDate | 2024 |
| publishDateSearch | 2024 |
| publishDateSort | 2024 |
| publisher | IGI Global |
| record_format | marc |
| series2 | Advances in medical diagnosis, treatment, and care (AMDTC) book series |
| spelling | Critical developments in cancer immunotherapy Mohsen Sheykhhasan, Piao Yang, Naresh Poondla, editors Hershey, Pennsylvania IGI Global 2024 1 Online-Ressource (xxi, 626 Seiten) txt rdacontent c rdamedia cr rdacarrier Advances in medical diagnosis, treatment, and care (AMDTC) book series Cancer still poses a significant challenge in healthcare since traditional treatments often fail to produce desired results and patient outcomes. Conventional therapies, like chemotherapy and radiation, can have substantial side effects and may not always be able to eliminate cancer cells. Moreover, the heterogeneity of tumors and individual responses to treatment create barriers to achieving consistent and long-lasting outcomes. Critical Developments in Cancer Immunotherapy offers a compelling solution to these challenges by delving into the cutting-edge field of cancer immunotherapy. This book provides a comprehensive guide to the latest advancements in harnessing the body's immune system to fight cancer. Focusing on critical strategies like checkpoint inhibitors and CAR T-cell therapy, the book provides insights into novel approaches that offer greater precision and effectiveness in cancer treatment. Cancer Immunotherapy Immunotherapy Poondla, Naresh edt Sheykhhasan, Mohsen edt Yang, Piao edt Erscheint auch als Druck-Ausgabe 9798369339763 https://doi.org/10.4018/979-8-3693-3976-3 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Critical developments in cancer immunotherapy Cancer Immunotherapy Immunotherapy |
| title | Critical developments in cancer immunotherapy |
| title_auth | Critical developments in cancer immunotherapy |
| title_exact_search | Critical developments in cancer immunotherapy |
| title_full | Critical developments in cancer immunotherapy Mohsen Sheykhhasan, Piao Yang, Naresh Poondla, editors |
| title_fullStr | Critical developments in cancer immunotherapy Mohsen Sheykhhasan, Piao Yang, Naresh Poondla, editors |
| title_full_unstemmed | Critical developments in cancer immunotherapy Mohsen Sheykhhasan, Piao Yang, Naresh Poondla, editors |
| title_short | Critical developments in cancer immunotherapy |
| title_sort | critical developments in cancer immunotherapy |
| topic | Cancer Immunotherapy Immunotherapy |
| topic_facet | Cancer Immunotherapy Immunotherapy |
| url | https://doi.org/10.4018/979-8-3693-3976-3 |
| work_keys_str_mv | AT poondlanaresh criticaldevelopmentsincancerimmunotherapy AT sheykhhasanmohsen criticaldevelopmentsincancerimmunotherapy AT yangpiao criticaldevelopmentsincancerimmunotherapy |